Literature DB >> 32948347

Botulinum Toxin for the Treatment of Intractable Raynaud Phenomenon.

Jose E Gallegos1, Dani C Inglesby1, Zachary T Young2, Fernando A Herrera3.   

Abstract

Raynaud phenomenon (RP) is a condition causing vasospasm in the fingers and toes of patients that can have a significant negative impact on quality of life. This can lead to pain, ulceration, and possible loss of digits. Several pharmacological options are available for treatment. However, RP can often be refractory to traditional modalities, leaving surgery or injections as the next available options. This article provides a review and update on the use of botulinum toxin as an effective therapy for the treatment of RP refractory to medical management.
Copyright © 2021 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BOTOX; Dysport; Raynaud; botulinum toxin; vasospasm

Year:  2020        PMID: 32948347     DOI: 10.1016/j.jhsa.2020.07.009

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  2 in total

1.  Botulinum Toxin A for the Treatment of Sympathomimetic Pressor-Induced Digital Hand Ischemia in the Critically Ill Intensive Care Unit Patient.

Authors:  Henning De May; Avra S Laarakker; Gregory Borah
Journal:  Hand (N Y)       Date:  2022-02-21

2.  Is axillary botulinum toxin efficient in controlling secondary Raynaud's phenomenon? A case report.

Authors:  David DeMasters; Emily Sturgill; Alan Bartholomew
Journal:  J Scleroderma Relat Disord       Date:  2021-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.